Cargando…
Pharmacovigilance Programme of India: Recent developments and future perspectives
Promoting safe use of medicines is a priority of Indian Pharmacopoeia Commission that functions as the National Coordination Center (NCC) for Pharmacovigilance Programme of India (PvPI). One hundred and seventy-nine adverse drug reactions (ADRs) monitoring centers currently report ADRs to NCC. Curre...
Autores principales: | Kalaiselvan, Vivekanandan, Thota, Prasad, Singh, Gyanendra Nath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155460/ https://www.ncbi.nlm.nih.gov/pubmed/28066097 http://dx.doi.org/10.4103/0253-7613.194855 |
Ejemplares similares
-
Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014) -
Veterinary pharmacovigilance in India: A need of hour
por: Kumar, Rishi, et al.
Publicado: (2017) -
Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017) -
Vaccine pharmacovigilance in India: Current context and future perspective
por: Meher, Bikash Ranjan
Publicado: (2019) -
“ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India
por: Prakash, Jai, et al.
Publicado: (2019)